Stockscreener 앱 받기
0.4582
0.87%
-0.004
시간 외 거래:
.44
-0.0182
-3.97%
Transcode Therapeutics Inc 주식(RNAZ)의 최신 뉴스
RNAZ stock touches 52-week low at $0.43 amid sharp annual decline - Investing.com
TransCode Therapeutics Inc’s Stock Price Plummeted Recently, But There Might Be Trouble Ahead - stocksregister.com
TransCode Therapeutics Delays Annual Report Filing - TipRanks
TransCode Therapeutics (RNAZ) Expected to Announce Earnings on Monday - Defense World
Emerging Tech QuartetPRSO, LXRX, PRTG, RNAZDrive - openPR.com
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
TransCode Therapeutics stock slides after announces to raise $10M securities offering - MSN
(RNAZ) Investment Analysis - news.stocktradersdaily.com
Small Cap Stocks To Follow TodayMarch 23rd - MarketBeat
TransCode Therapeutics, Inc. Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial Withttx-Mc138 - MarketScreener
TransCode Therapeutics Starts Dosing for Experimental Cancer Treatment in Early Trial - Marketscreener.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
TransCode's $10M Capital Raise Powers Critical Cancer Drug Clinical Trials - Stock Titan
Transcode Therapeutics stock hits 52-week low at $0.64 By Investing.com - Investing.com Australia
TransCode Therapeutics Announces $10M Stock And Warrant Offering - Nasdaq
Sector Update: Health Care Stocks Rise Late Afternoon - TradingView
Transcode Therapeutics stock hits 52-week low at $0.64 - Investing.com India
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Transcode to sell 10.25M shares at 98c per share in registered direct offering - TipRanks
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
TransCode Therapeutics Starts $10 Million Direct Offering of Stock, Warrants -March 24, 2025 at 03:42 am EDT - Marketscreener.com
$10M Capital Raise: TransCode Therapeutics Accelerates TTX-MC138 Clinical Trials - Stock Titan
TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - PR Newswire
Small Cap Stocks To ResearchMarch 21st - MarketBeat
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
(RNAZ) Long Term Investment Analysis - Stock Traders Daily
HC Wainwright Reaffirms “Buy” Rating for TransCode Therapeutics (NASDAQ:RNAZ) - Defense World
RNAZ stock touches 52-week low at $0.69 amid sharp annual decline - Investing.com Canada
Biotech Alert: Searches spiking for these stocks today - TipRanks
SRC approves opening of TransCode’s fourth cohort in trial of TTX-MC138 - Yahoo Finance
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
TransCode Therapeutics Advances Phase I Trial Of RNA Cancer Therapy - Nasdaq
Transcode Therapeutics’ fourth cohort in Phase 1/2 cancer trial approved - TipRanks
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
TransCode Therapeutics Says Safety Review Committee Approves Opening of Fourth Group in Phase 1 Trial to Treat Metastatic Cancers - Marketscreener.com
TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial - Longview News-Journal
Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews
Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care - Cancer Network
Transcode Therapeutics stock hits 52-week low at $1.7 By Investing.com - Investing.com Canada
Transcode Therapeutics stock hits 52-week low at $1.7 - Investing.com
Pre-market Movers: PRFX, BJDX, TARA, PBM... - RTTNews
The Significance of Moving Averages in TransCode Therapeutics Inc Inc. (RNAZ) Price Performance - The InvestChronicle
Transcode Therapeutics stock hits 52-week low at $2.62 By Investing.com - Investing.com South Africa
Transcode Therapeutics stock hits 52-week low at $2.62 - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com UK
TransCode Therapeutics, Inc. Announces Results of Special Meeting - Yahoo Finance
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast - Benzinga India
Learn to Evaluate (RNAZ) using the Charts - Stock Traders Daily
10.70%
자본화:
|
볼륨(24시간):